Cargando…

Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B

BACKGROUND: Restoration of HBV-specific T cell immunity is a promising approach for the functional cure of chronic Hepatitis B (CHB), necessitating the development of valid assays to boost and monitor HBV-specific T cell responses in patients with CHB. METHODS: We analyzed hepatitis B virus (HBV) co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yu-Long, Zhou, Shuang-Nan, Hu, Wei, Li, Jing, Zhou, Ming-Ju, Li, Xiao-Yu, Wang, You-Yuan, Zhang, Peng, Chen, Si-Yuan, Fan, Xing, Song, Jin-Wen, Jiao, Yan-Mei, Xu, Ruonan, Zhang, Ji-Yuan, Zhen, Cheng, Zhou, Chun-Bao, Yuan, Jin-Hong, Shi, Ming, Wang, Fu-Sheng, Zhang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522531/ https://www.ncbi.nlm.nih.gov/pubmed/36976426 http://dx.doi.org/10.1007/s12072-023-10490-4

Ejemplares similares

Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
por: Zhang, Chao, et al.
Publicado: (2023)

Cured HCV patients with suboptimal hepatitis B vaccine response exhibit high self-reactive immune signatures
por: Zhou, Ming-Ju, et al.
Publicado: (2023)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
por: Sun, Yeping, et al.
Publicado: (2018)

Establishment and validation of a diagnostic nomogram for significant histopathologic changes of hepatic injury in HBV-infected patients
por: Sun, Lin-Lin, et al.
Publicado: (2023)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapy
por: Wang, You-Yuan, et al.
Publicado: (2023)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection
por: Wan, Lin-Yu, et al.
Publicado: (2022)

Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients
por: Wang, Wen-Xin, et al.
Publicado: (2023)

Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins
por: Zhang, Jing, et al.
Publicado: (2021)

Reversal of the CD8(+) T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
por: Li, Jing, et al.
Publicado: (2021)

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
por: Meng, Fanping, et al.
Publicado: (2021)

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy
por: Pan, Shida, et al.
Publicado: (2022)

Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B
por: Zhou, Shuang-Nan, et al.
Publicado: (2020)

Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients
por: Liu, Kai, et al.
Publicado: (2021)

SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
por: Wu, Dai-Qing, et al.
Publicado: (2022)

Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Zhang, Hao, et al.
Publicado: (2023)

Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Xu, Ruonan, et al.
Publicado: (2016)

SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope
por: Liu, Yue, et al.
Publicado: (2020)

Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment
por: Zhang, Ji-Yuan, et al.
Publicado: (2010)

CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV‐1−Infected Individuals on Antiretroviral Therapy
por: Hu, Wei, et al.
Publicado: (2022)

Can G-quadruplex become a promising target in HBV therapy?
por: Teng, Ye, et al.
Publicado: (2022)

Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis
por: Zhang, Yuan, et al.
Publicado: (2021)

5′ preS1 Mutations To Prevent Large Envelope Protein Expression from Hepatitis B Virus Genotype A or Genotype D Markedly Increase Polymerase-Envelope Fusion Protein
por: Zhang, Jing, et al.
Publicado: (2022)

An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice
por: Yuan, Lunzhi, et al.
Publicado: (2016)

Changes of Damage Associated Molecular Patterns in COVID-19 Patients
por: Fan, Xing, et al.
Publicado: (2021)

An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
por: Zhang, Bin, et al.
Publicado: (2023)

Radiomics‐based classification models for HBV‐related cirrhotic patients with covert hepatic encephalopathy
por: Luo, Sha, et al.
Publicado: (2020)

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Gao, Xing-hui, et al.
Publicado: (2017)

Two Classifiers Based on Serum Peptide Pattern for Prediction of HBV-Induced Liver Cirrhosis Using MALDI-TOF MS
por: Cao, Yuan, et al.
Publicado: (2013)

Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China
por: Li, Si-Yue, et al.
Publicado: (2011)

Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression
por: Cao, Wen-Jing, et al.
Publicado: (2022)

HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART
por: Zhang, Lu-Xue, et al.
Publicado: (2020)

Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells
por: Zhou, Ming, et al.
Publicado: (2017)

Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
por: Perez-Vargas, Jimena, et al.
Publicado: (2019)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Metabolic Regulation of Hepatitis B Virus Infection in HBV-Transgenic Mice
por: Lan, Wenning, et al.
Publicado: (2022)

Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet
por: Sun, Nan, et al.
Publicado: (2014)

HIV-1 Envelope Glycoprotein Variable Loops Are Indispensable for Envelope Structural Integrity and Virus Entry
por: Yuan, Tingting, et al.
Publicado: (2013)

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice
por: Qi, Ruoyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8aotnr6e90ig2h01r39a5kef76